You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY20 is not expected to be complete until September, 2021.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

  1. STTR Phase I: Rapid Hemostatic Dressing for Hemorrhage Control

    SBC: Gamma Therapeutics, Inc.            Topic: BM

    The broader impact/commercial potential of this Small Business Technology Transfer (STTR) Phase I project is to enable rapid blood clotting in order to treat bleeding after a traumatic injury The majority of deaths that occur within the first 24 hours following a traumatic injury are the result of hemorrhage. The scientific merits of the project stem from the biochemical advantages of using the ph ...

    STTR Phase I 2016 National Science Foundation
  2. STTR Phase I: Commercialization of Synthetic Metabolic Valves

    SBC: DMC Biotechnologies, Inc.            Topic: BT

    The broader impact/commercial potential of this Small Business Technology Transfer (STTR) project will be the development of technology to decouple growth from product formation in microbes used for biomanufacturing. The goal is to address current limitations in the field of metabolic engineering for the production of high value products. Current approaches must balance the complex requirements of ...

    STTR Phase I 2016 National Science Foundation
  3. STTR Phase I: Termite-derived enzymatic tree bio-herbicides

    SBC: Ento Bio LLC            Topic: CT

    The broader impact/commercial potential of this Small Business Innovation Research Phase I project is a novel tree bio-herbicide to prevent sprouting of stumps and girdled trees. If successful, it would replace synthetic chemical herbicides currently used to stop stump sprouting, cull unwanted trees, prevent disease, and control invasive species in national parks and forests, managed timberlands, ...

    STTR Phase I 2016 National Science Foundation
  4. STTR Phase I: Additive manufacturing of ceramic composites for next generation gas turbines

    SBC: American Manufacturing LLC            Topic: MN

    The broader impact/commercial potential of this project lies in next generation gas turbines where the heart of the engine, the combustor and the blade, are constructed from ceramic matrix composites (CMCs). These developments will spell a new phase of air transportation beyond the current engines that rely upon nickel-base superalloys, which have reached their maximum capability. The ceramic engi ...

    STTR Phase I 2016 National Science Foundation
  5. STTR Phase I: Triboluminescent sensor system for quasi-distributed load sensing on wind blades for active control of wind turbines

    SBC: NANOTECHNOLOGY PATRONAS GROUP INC            Topic: MI

    This Small Business Technology Transfer Phase I project is for the development of a triboluminescent sensor system (ITOFPress) for quasi-distributed load sensing along the length of a wind blade for active control of wind turbines. According to experts, this innovation could result in a 20% increase in wind turbine power generation through enhanced inputs for active turbine control and better unde ...

    STTR Phase I 2016 National Science Foundation
  6. STTR Phase I: Cooperative Selection of Aptamer Pairs by Unlocking Parallel Enrichment Paths

    SBC: Proximity Biosciences LLC            Topic: BT

    The broader impact/commercial potential of this Small Business Technology Transfer (STTR) Phase I project will be to develop reliable technology for the production of aptamer pairs. Aptamers are core reagents in emerging markets, regarded as alternatives to monoclonal antibodies in therapeutics, diagnostics, and imaging. They possess several appealing qualities: Ease of in vitro synthesis, flexibl ...

    STTR Phase I 2016 National Science Foundation
  7. STTR Phase I: Continuous Production and Collection of Magnesium via Carbothermal Reduction

    SBC: Big Blue Technologies LLC            Topic: MN

    This STTR Phase I project addresses the problem of embedded energy in the manufacture of magnesium metal for use in vehicle light-weighting. Improving fuel economy by incorporation of light metals, especially magnesium, does not save on total lifecycle energy consumed if the magnesium was produced using conventional methods. The most energy efficient production method known is a process technology ...

    STTR Phase I 2016 National Science Foundation
  8. STTR Phase I: A Platform Reagent for the Intracellular Delivery of Positively Charged Peptide

    SBC: MOERAE MATRIX INC            Topic: BT

    The broader impact/commercial potential of this Small Business Technology Transfer (STTR) project will be to develop an intracellular delivery technology for positively charged peptides for use in cell experiments in basic laboratory science and for delivery of peptide therapeutics for treatment of human disease. Peptides hold many advantages over the small molecule drugs that dominate the current ...

    STTR Phase I 2016 National Science Foundation
  9. High Fidelity Computational Models for Aggregated Tissue Interaction in Surgical Simulations

    SBC: CFD Research Corporation            Topic: DHP16A001

    Surgical simulations aiming to support surgeon practices and medical education have attracted enormous research effort over the last two decades. However, the physical reality, especially on simulating aggregated tissue interaction, is still unsatisfactory. In this proposed work, an open source surgery simulation framework, SoFMIS, will be utilized and enhanced with tissue interaction models to a ...

    STTR Phase I 2016 Department of DefenseDefense Health Agency
  10. Use of Highly Porous Polymer Beads to Remove Anti-A and Anti-B Antibodies from Plasma for Transfusion

    SBC: CytoSorbents Medical Inc.            Topic: DHP15B001

    The ready availability of universal donor plasma to rapidly treat massively bleeding hospital trauma patients and warfighters with combat casualties is a key element of current recommendations for trauma resuscitation, yet universal AB donor plasma is rel

    STTR Phase I 2016 Department of DefenseDefense Health Agency
US Flag An Official Website of the United States Government